Fibrinolysis for intermediate-risk pulmonary embolism.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  New England Journal of Medicine

• Publication date

  2014-08-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMc1406283PMID 25099593PMCID PMC4375437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibrinolysis for patients with intermediate-risk pulmonary embolism.

  2014cited by this paper
• Fibrinolysis of pulmonary emboli--steer closer to Scylla.

  2014cited by this paper
• Moderate pulmonary embolism treated with thrombolysis (from the "MOPETT" Trial).

  2013cited by this paper
• Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy

  2013cited by this paper
• Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.

  2013cited by this paper
• A strategy combining imaging and laboratory biomarkers in comparison with a simplified clinical score for risk stratification of patients with acute pulmonary embolism.

  2012cited by this paper
• Detection of tPA-Induced Hyperfibrinolysis in Whole Blood by RapidTEG, KaolinTEG, and Functional FibrinogenTEG in Healthy Individuals

  2012cited by this paper
• Six-Month Echocardiographic Study in Patients With Submassive Pulmonary Embolism and Right Ventricle Dysfunction: Comparison of Thrombolysis With Heparin

  2011cited by this paper
• Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure.

  2009cited by this paper
• Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.

  2005cited by this paper
• Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

  2004cited by this paper
• Right Ventricular Enlargement on Chest Computed Tomography: Prognostic Role in Acute Pulmonary Embolism

  2004cited by this paper
• Pharmacokinetics of a low molecular weight heparin [Fragmin] in young and elderly subjects.

  1992cited by this paper
• Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1).

  1989cited by this paper

• Thromboses vasculaires et Covid-19

  2024cites this paper
• In-hospital mortality of high-risk pulmonary embolism: a nationwide population-based cohort study in Portugal from 2010 to 2018.

  2024cites this paper
• Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients

  2022cites this paper
• Maladie thromboembolique veineuse et Covid-19

  2022cites this paper
• Mansoor's Self‐Report Tool for Cardiovascular Risk Assessment predicts adverse in‐hospital events in patients with pulmonary embolism

  2022cites this paper
• Catheter-Directed Thrombolysis for Pulmonary Embolism: Will Novel Technology Improve Outcomes?

  2022cites this paper
• Aggressive Therapy for Acute Pulmonary Embolism: Systemic Thrombolysis and Catheter-Directed Approaches

  2021cites this paper
• GITEPen 5 urteko esperientzia Gipuzkoan: diziplina anitzeko taldea biriketako tronboenbolismo akutu larriaren artatze integralerako

  2021cites this paper
• Mechanical Thrombectomy in Pulmonary Embolism: Ready for Prime Time?

  2021cites this paper
• Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19: CHEST Guideline and Expert Panel Report

  2020cites this paper
• The 2019 ESC guidelines on pulmonary embolism: some further insights.

  2020cites this paper
• Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019

  2020cites this paper
• Current Controversies in Caring for the Critically Ill Pulmonary Embolism Patient.

  2020cites this paper
• Predictive value of the Kuijer score for bleeding and other adverse in-hospital events in patients with venous thromboembolism.

  2020cites this paper
• When appearances deceive: Echocardiographic changes due to common chest pathology

  2018cites this paper
• D‐Dimer and thrombus burden in acute pulmonary embolism

  2018cites this paper
• Use of Tachycardia in Patients With Submassive Pulmonary Emboli to Risk Stratify for Early Initiation of Thrombolytic Therapy: A Case Series Comparing Early Versus Late Thrombolytic Initiation

  2017influential citation
• Renal function as a cofactor for risk stratification and short‐term outcome in acute pulmonary embolism☆☆☆

  2017cites this paper
• Embolie pulmonaire : histoire naturelle, diagnostic, traitement

  2017cites this paper
• Quantification of Treatment Effect Modification on Both an Additive and Multiplicative Scale

  2016cites this paper
• Elevated systolic pulmonary artery pressure for prediction of myocardial necrosis and right ventricular dysfunction in acute pulmonary embolism

  2016cites this paper
• Shock index for outcome and risk stratification in acute pulmonary embolism

  2016cites this paper
• D-dimer for risk stratification in haemodynamically stable patients with acute pulmonary embolism.

  2015cites this paper
• Continuous intraperitoneal insulin infusion (CIPII) for type 1 diabetes: Effective therapy but a case of bad timing?

  2015influential citation
• Modified Bova score for risk stratification and short-term outcome in acute pulmonary embolism.

  2015influential citation
• Systematic Review/meta-analysis

  year unknowncites this paper